Sonoma Pharmaceuticals Inc (SNOA) — Financial Flexibility Index
Sonoma Pharmaceuticals Inc (SNOA) has a Financial Flexibility Index of -0.06x as of June 2026. Free cash flow of $-647.00K (operating CF $-649.00K minus capex $2.00K) represents 0% of total liabilities ($11.51 Million). Check SNOA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sonoma Pharmaceuticals Inc Financial Flexibility Index (2005–2026)
Historical Financial Flexibility Index trend for Sonoma Pharmaceuticals Inc across 22 annual periods. For the full cash flow conversion analysis, see how efficiently does Sonoma Pharmaceuticals Inc generate cash.
Annual Financial Flexibility Index for Sonoma Pharmaceuticals Inc (2005–2026)
Year-by-year free cash flow to debt coverage for Sonoma Pharmaceuticals Inc. Explore cash flow to debt ratio of Sonoma Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | -0.34x | $-3.74 Million | $-3.93 Million | $10.87 Million | ▼ -39849.3% |
| 2025 | 0.00x | $-8.00K | $-88.00K | $9.28 Million | ▲ +99.7% |
| 2024 | -0.28x | $-2.38 Million | $-2.40 Million | $8.60 Million | ▲ +61.2% |
| 2023 | -0.71x | $-5.88 Million | $-6.15 Million | $8.25 Million | ▼ -75.9% |
| 2022 | -0.41x | $-4.11 Million | $-4.25 Million | $10.15 Million | ▼ -21.9% |
| 2021 | -0.33x | $-3.20 Million | $-3.38 Million | $9.62 Million | ▲ +32.3% |
| 2020 | -0.49x | $-4.38 Million | $-4.59 Million | $8.94 Million | ▲ +83.3% |
| 2019 | -2.93x | $-11.62 Million | $-11.72 Million | $3.96 Million | ▲ +7.1% |
| 2018 | -3.16x | $-12.25 Million | $-12.44 Million | $3.88 Million | ▼ -63.6% |
| 2017 | -1.93x | $-7.77 Million | $-8.17 Million | $4.03 Million | ▲ +15.9% |
| 2016 | -2.29x | $-8.40 Million | $-8.75 Million | $3.66 Million | ▼ -4.8% |
| 2015 | -2.19x | $-6.55 Million | $-6.69 Million | $2.99 Million | ▼ -335.7% |
| 2014 | -0.50x | $-4.39 Million | $-4.89 Million | $8.73 Million | ▼ -403.0% |
| 2013 | 0.17x | $1.41 Million | $1.15 Million | $8.48 Million | ▲ +139.1% |
| 2012 | -0.42x | $-3.70 Million | $-4.03 Million | $8.71 Million | ▲ +30.5% |
| 2011 | -0.61x | $-4.25 Million | $-4.43 Million | $6.96 Million | ▲ +70.2% |
| 2010 | -2.05x | $-6.50 Million | $-6.64 Million | $3.17 Million | ▲ +60.4% |
| 2009 | -5.17x | $-16.44 Million | $-16.83 Million | $3.18 Million | ▼ -151.6% |
| 2008 | -2.06x | $-16.83 Million | $-17.45 Million | $8.18 Million | ▼ -44.0% |
| 2007 | -1.43x | $-17.21 Million | $-18.08 Million | $12.05 Million | ▲ +61.9% |
| 2006 | -3.75x | $-20.05 Million | $-20.52 Million | $5.35 Million | ▼ -42.1% |
| 2005 | -2.64x | $-12.49 Million | $-13.53 Million | $4.74 Million | — |